Literature DB >> 12055808

Clinical and immunological risk factors for severe disease in Japanese encephalitis.

Daniel H Libraty1, Ananda Nisalak, Timothy P Endy, Saroj Suntayakorn, David W Vaughn, Bruce L Innis.   

Abstract

Eighty-five paediatric patients in Thailand with acute Japanese encephalitis (JE) were studied in 1987-99 to determine risk factors present at hospital admission which were associated with severe disease. On univariate analysis, the following factors on admission were significantly associated with the combined end-point of death or a severe neurological deficit: depressed level of consciousness, elevated concentration of cerebrospinal fluid (CSF) protein, low levels of serum and CSF IgG antibody against Japanese encephalitis virus (JEV), low level of serum IgM antibody against JEV, and a serological response consistent with primary flavivirus infection. On multivariate analysis, an initial serum anti-JEV IgM < 150 U and the absence of a prior flavivirus infection, presumably dengue, remained independent risk factors for death or a severe neurological deficit. The ability to mount an early and vigorous JEV-reactive antibody response is associated with a better outcome from acute JE. An anamnestic, anti-flavivirus, immune response induced by a prior dengue virus infection can be an important means of providing this protection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055808     DOI: 10.1016/s0035-9203(02)90294-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  34 in total

1.  Entomopathogenic marine actinomycetes as potential and low-cost biocontrol agents against bloodsucking arthropods.

Authors:  Karthik Loganathan; Gaurav Kumar; Arivarasan Vishnu Kirthi; Kokati Venkata Bhaskara Rao; Abdul Abdul Rahuman
Journal:  Parasitol Res       Date:  2013-09-08       Impact factor: 2.289

2.  A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence.

Authors:  Mélissanne de Wispelaere; Marie-Pascale Frenkiel; Philippe Desprès
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

3.  Insecticidal and larvicidal activities of medicinal plant extracts against mosquitoes.

Authors:  Chinnaperumal Kamaraj; Abdul Abdul Rahuman; Anita Mahapatra; Asokan Bagavan; Gandhi Elango
Journal:  Parasitol Res       Date:  2010-08-06       Impact factor: 2.289

4.  Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis.

Authors:  Maximilian Larena; Matthias Regner; Eva Lee; Mario Lobigs
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  New vaccines for Japanese encephalitis.

Authors:  Scott B Halstead; Stephen J Thomas
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

6.  Response to Hossain and others: hospital-based surveillance for Japanese encephalitis at four sites in Bangladesh, 2003-2005.

Authors:  Penny Lewthwaite; Tom Solomon
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

7.  A cohort study to assess the new WHO Japanese encephalitis surveillance standards.

Authors:  Tom Solomon; Thi Thu Thao; Penny Lewthwaite; Mong How Ooi; Rachel Kneen; Nguyen Minh Dung; Nicholas White
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

8.  Effect of prior dengue infection on severity and outcome of Japanese encephalitis.

Authors:  A Verma; A Jain; C Kumar; M Agarwal; R Kumar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-02-06       Impact factor: 3.267

9.  Clinical presentation, etiology, and survival in adult acute encephalitis syndrome in rural Central India.

Authors:  Rajnish Joshi; Pradyumna Kumar Mishra; Deepti Joshi; S R Santhosh; M M Parida; Prabha Desikan; Nitin Gangane; S P Kalantri; Arthur Reingold; John M Colford
Journal:  Clin Neurol Neurosurg       Date:  2013-05-01       Impact factor: 1.876

10.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.